Asberg M, Cronholm B, Sjöqvist F, Tuck D
Br Med J. 1970 Oct 3;4(5726):18-21. doi: 10.1136/bmj.4.5726.18.
Plasma levels of tricyclic antidepressant drugs vary considerably between individuals receiving the same amount of drug. The bearing of this variation on the occurrence of subjective side effects was investigated in 40 psychiatric inpatients with depressive disorders. Plasma levels were determined before and during four weeks of treatment with nortriptyline 50 mg. three times a day and patients were rated for subjective side effects, the assessors being unaware of the plasma levels of the drug.Plasma levels varied widely between individual patients, but in any given patient the plasma level tended to be constant over a period of time. The side effects of nortriptyline diminished significantly with time and were in most cases absent during the fourth week of treatment. There was a significant positive correlation between plasma level of nortriptyline and subjective side effects.The steady-state plasma level of a drug which is metabolized is usually a more important determinant for its effect than dosage, since it reflects the amount of drug available for biological action. Very high plasma levels of nortriptyline should presumably be avoided, since there is no evidence that they are needed for therapeutic effect and they are potentially harmful.
接受相同剂量药物的个体之间,三环类抗抑郁药物的血浆水平差异很大。在40名患有抑郁症的精神科住院患者中,研究了这种差异与主观副作用发生之间的关系。在每天三次服用50毫克去甲替林治疗的四周前及治疗期间测定血浆水平,并对患者的主观副作用进行评分,评估人员不知道药物的血浆水平。个体患者之间的血浆水平差异很大,但在任何给定患者中,血浆水平在一段时间内趋于恒定。去甲替林的副作用随时间显著减少,在治疗的第四周大多数情况下不存在。去甲替林的血浆水平与主观副作用之间存在显著正相关。对于经代谢的药物,其稳态血浆水平通常比剂量对其效果的影响更重要,因为它反映了可用于生物作用的药物量。应该避免去甲替林的血浆水平过高,因为没有证据表明治疗效果需要高血浆水平,而且高血浆水平可能有害。